Is DOTS-plus worth it for TB in developing countries?
KeywordsTuberculosis Hypothetical Cohort Antituberculosis Drug Additional Individual Acceptable Cost
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
© Adis International Ltd 2003